Xueqin Li

4.8k total citations · 1 hit paper
192 papers, 3.3k citations indexed

About

Xueqin Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xueqin Li has authored 192 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 29 papers in Cancer Research and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xueqin Li's work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (9 papers). Xueqin Li is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (10 papers) and MicroRNA in disease regulation (9 papers). Xueqin Li collaborates with scholars based in China, United States and Japan. Xueqin Li's co-authors include Kun Lv, Mengying Zhang, Qi Tang, Lingzhong Xu, Peipei Song, Songheng Jin, Weiya Pei, Xin Gou, Kaihui Hu and Jing Fan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xueqin Li

178 papers receiving 3.3k citations

Hit Papers

Multitargeted Immunomodulatory Therapy for Viral Myocardi... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueqin Li China 31 1.3k 634 389 372 371 192 3.3k
Qi Sun China 28 1.8k 1.3× 704 1.1× 270 0.7× 400 1.1× 191 0.5× 95 3.9k
Mingming Liu China 29 1.2k 0.9× 374 0.6× 299 0.8× 308 0.8× 308 0.8× 220 3.3k
Xi Wang China 30 1.3k 1.0× 570 0.9× 263 0.7× 259 0.7× 331 0.9× 169 3.0k
Huan Wang China 32 1.3k 1.0× 833 1.3× 258 0.7× 265 0.7× 407 1.1× 253 4.0k
Xiaoli Chen China 38 1.5k 1.1× 519 0.8× 440 1.1× 211 0.6× 326 0.9× 211 4.9k
Jianguo Wen China 35 1.6k 1.2× 519 0.8× 402 1.0× 464 1.2× 541 1.5× 296 4.5k
Afsane Bahrami Iran 32 1.7k 1.3× 867 1.4× 432 1.1× 600 1.6× 322 0.9× 144 3.9k
Ying Chen China 35 1.7k 1.2× 648 1.0× 218 0.6× 486 1.3× 482 1.3× 258 4.3k
Yang Yan China 30 1.0k 0.8× 355 0.6× 541 1.4× 334 0.9× 250 0.7× 245 3.7k
Jie Yang China 28 1.5k 1.1× 319 0.5× 284 0.7× 684 1.8× 379 1.0× 164 4.8k

Countries citing papers authored by Xueqin Li

Since Specialization
Citations

This map shows the geographic impact of Xueqin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqin Li more than expected).

Fields of papers citing papers by Xueqin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqin Li. The network helps show where Xueqin Li may publish in the future.

Co-authorship network of co-authors of Xueqin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqin Li. A scholar is included among the top collaborators of Xueqin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqin Li. Xueqin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Li, Xueqin, et al.. (2024). The impact of electricity sales side reform on energy technology innovation: An analysis based on SCP paradigm. Energy Economics. 136. 107763–107763. 3 indexed citations
4.
Zhang, Dagan, et al.. (2024). Label-free multiplexed detection based on core–shell photonic barcodes integrated RCA. Biosensors and Bioelectronics. 271. 117037–117037. 3 indexed citations
5.
Peng, Fei, Huanhuan Cao, Xueqin Li, et al.. (2024). Abstract 2712: Development of GB268, a tri-specific antibody targeting PD-1/CTLA-4/VEGF, with enhanced anti-tumor efficacy and reduced toxicity in pre-clinical studies. Cancer Research. 84(6_Supplement). 2712–2712. 1 indexed citations
6.
Li, Xueqin, et al.. (2023). New urbanization and carbon emissions intensity reduction: Mechanisms and spatial spillover effects. The Science of The Total Environment. 905. 167172–167172. 28 indexed citations
7.
Cao, Xingqi, Xueqin Li, Xiaoyi Sun, et al.. (2023). Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study. JMIR Public Health and Surveillance. 9. e45502–e45502. 17 indexed citations
8.
Zhu, Li, Xiaohong Chen, Yue Zhang, et al.. (2023). Higher CD4+CD40+ T cells (Th40 cells) associate with systemic lupus erythematosus activity. Scientific Reports. 13(1). 10702–10702. 4 indexed citations
9.
Cao, Xingqi, Xin Li, Xueqin Li, et al.. (2023). Associations of Midlife Dietary Patterns with Incident Dementia and Brain Structure: Findings from the UK Biobank Study. American Journal of Clinical Nutrition. 118(1). 218–227. 24 indexed citations
10.
Cao, Xingqi, Jingyun Zhang, Chao Ma, et al.. (2022). Life course traumas and cardiovascular disease—the mediating role of accelerated aging. Annals of the New York Academy of Sciences. 1515(1). 208–218. 7 indexed citations
11.
Xu, Yang, Xiaodong Wu, Wenjie Hu, et al.. (2021). RIP3 facilitates necroptosis through CaMKII and AIF after intracerebral hemorrhage in mice. Neuroscience Letters. 749. 135699–135699. 18 indexed citations
12.
Zhou, Jing, Ji Zhang, Jiayi Li, et al.. (2021). Ginsenoside F2 Suppresses Adipogenesis in 3T3-L1 Cells and Obesity in Mice via the AMPK Pathway. Journal of Agricultural and Food Chemistry. 69(32). 9299–9312. 38 indexed citations
13.
Hu, Kaihui, et al.. (2020). The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine. 99(24). e20603–e20603. 142 indexed citations
14.
Zhang, Lijuan, Xueqin Li, Cunde Wang, et al.. (2018). The Correlation of Visfatin and Its Gene Polymorphism with Non-Small Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals. 33(10). 460–465. 4 indexed citations
16.
Xia, Shuang, Xueqin Li, Yanbin Shi, et al.. (2016). A Retrospective Cohort Study of Lesion Distribution of HIV-1 Infection Patients With Cryptococcal Meningoencephalitis on MRI. Medicine. 95(6). e2654–e2654. 11 indexed citations
17.
Wu, Lei, Xueqin Li, Haifeng Wu, et al.. (2016). 5-Methoxyl Aesculetin Abrogates Lipopolysaccharide-Induced Inflammation by Suppressing MAPK and AP-1 Pathways in RAW 264.7 Cells. International Journal of Molecular Sciences. 17(3). 315–315. 31 indexed citations
18.
Li, Xueqin. (2012). Traditional Chinese Medicine for the Treatment of Generalized Anxiety Disorder Research Progress. 1 indexed citations
19.
Li, Xueqin, et al.. (2009). In vitro shoot culture and rapid propagation of Chinese tallow trees for energy forests.. Dongbei linye daxue xuebao. 37(12). 8–42. 4 indexed citations
20.
Li, Xueqin. (2007). Effect of edaravone on neurological rehabilitation after hypertensive intracerebral hemorrhage. Anhui Medical and Pharmaceutical Journal. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026